{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T19:05:34Z","timestamp":1795201534772,"version":"4.10.3"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T00:00:00Z","timestamp":1530230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T00:00:00Z","timestamp":1530230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2014CB910800"],"award-info":[{"award-number":["2014CB910800"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDPB03"],"award-info":[{"award-number":["XDPB03"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Oridonin (Ori) is the major active ingredient of the traditional Chinese medicinal herb\n                    <jats:italic>Rabdosia rubescens<\/jats:italic>\n                    and has anti-inflammatory activity, but the target of Ori remains unknown. NLRP3 is a central component of NLRP3 inflammasome and has been involved in a wide variety of chronic inflammation-driven human diseases. Here, we show that Ori is a specific and covalent inhibitor for NLRP3 inflammasome. Ori forms a covalent bond with the cysteine 279 of NLRP3 in NACHT domain to block the interaction between NLRP3 and NEK7, thereby inhibiting NLRP3 inflammasome assembly and activation. Importantly, Ori has both preventive or therapeutic effects on mouse models of peritonitis, gouty arthritis and type 2 diabetes, via inhibition of NLRP3 activation. Our results thus identify NLRP3 as the direct target of Ori for mediating Ori\u2019s anti-inflammatory activity. Ori could serve as a lead for developing new therapeutics against NLRP3-driven diseases.\n                  <\/jats:p>","DOI":"10.1038\/s41467-018-04947-6","type":"journal-article","created":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T10:29:34Z","timestamp":1529922574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":783,"title":["Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity"],"prefix":"10.1038","volume":"9","author":[{"given":"Hongbin","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3192-2780","authenticated-orcid":false,"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7829-2547","authenticated-orcid":false,"given":"Qingsong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6159-9999","authenticated-orcid":false,"given":"Gaolin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianming","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3351-6420","authenticated-orcid":false,"given":"Rongbin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,29]]},"reference":[{"key":"4947_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0934-8840(97)80076-X","volume":"286","author":"S Kadota","year":"1997","unstructured":"Kadota, S., Basnet, P., Ishii, E., Tamura, T. & Namba, T. Antibacterial activity of trichorabdal A from Rabdosia trichocarpa against Helicobacter pylori. Zent. fur Bakteriol.: Int. J. Med. Microbiol. 286, 63\u201367 (1997).","journal-title":"Zent. fur Bakteriol.: Int. J. Med. Microbiol."},{"key":"4947_CR2","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.3390\/molecules19033327","volume":"19","author":"LM Kuo","year":"2014","unstructured":"Kuo, L. M. et al. Intracellular glutathione depletion by oridonin leads to apoptosis in hepatic stellate cells. Molecules 19, 3327\u20133344 (2014).","journal-title":"Molecules"},{"key":"4947_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ejmech.2016.06.015","volume":"122","author":"Y Ding","year":"2016","unstructured":"Ding, Y. et al. Discovery and development of natural product oridonin-inspired anticancer agents. Eur. J. Med. Chem. 122, 102\u2013117 (2016).","journal-title":"Eur. J. Med. Chem."},{"key":"4947_CR4","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1248\/cpb.24.2118","volume":"24","author":"E Fujita","year":"1976","unstructured":"Fujita, E., Nagao, Y., Kaneko, K., Nakazawa, S. & Kuroda, H. The antitumor and antibacterial activity of the Isodon diterpenoids. Chem. Pharm. Bull. 24, 2118\u20132127 (1976).","journal-title":"Chem. Pharm. Bull."},{"key":"4947_CR5","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s11596-009-0525-2","volume":"29","author":"S Chen","year":"2009","unstructured":"Chen, S., Liu, J. & Zhang, H. Efficacy of rabdosia rubescens in the treatment of gingivitis. J. Huazhong Univ. Sci. Technol. Med. Sci. 29, 659\u2013663 (2009).","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"4947_CR6","first-page":"170","volume":"36","author":"Z Ma","year":"2011","unstructured":"Ma, Z., Hu, C. & Zhang, Y. Therapeutic effect of Rabdosia rubescens aqueous extract on chronic pharyngitis and its safety. J. Central South Univ. Med. Sci. 36, 170\u2013173 (2011).","journal-title":"J. Central South Univ. Med. Sci."},{"key":"4947_CR7","first-page":"261","volume":"59","author":"J Huang","year":"2005","unstructured":"Huang, J., Wu, L., Tashiro, S., Onodera, S. & Ikejima, T. A comparison of the signal pathways between the TNF alpha- and oridonin-induced murine L929 fibrosarcoma cell death. Acta Med. Okayama 59, 261\u2013270 (2005).","journal-title":"Acta Med. Okayama"},{"key":"4947_CR8","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.intimp.2009.01.002","volume":"9","author":"Y Xu","year":"2009","unstructured":"Xu, Y. et al. Multiple-modulation effects of Oridonin on the production of proinflammatory cytokines and neurotrophic factors in LPS-activated microglia. Int. Immunopharmacol. 9, 360\u2013365 (2009).","journal-title":"Int. Immunopharmacol."},{"key":"4947_CR9","doi-asserted-by":"crossref","first-page":"68153","DOI":"10.18632\/oncotarget.19249","volume":"8","author":"G Zhao","year":"2017","unstructured":"Zhao, G. et al. Oridonin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-induced RAW264.7 cells and acute lung injury. Oncotarget 8, 68153\u201368164 (2017).","journal-title":"Oncotarget"},{"key":"4947_CR10","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/jgh.12710","volume":"30","author":"S Wang","year":"2015","unstructured":"Wang, S. et al. Oridonin\u2019s therapeutic effect: suppressing Th1\/Th17 simultaneously in a mouse model of Crohn\u2019s disease. J. Gastroenterol. Hepatol. 30, 504\u2013512 (2015).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"4947_CR11","doi-asserted-by":"publisher","first-page":"e104745","DOI":"10.1371\/journal.pone.0104745","volume":"9","author":"S Wang","year":"2014","unstructured":"Wang, S. et al. Oridonin attenuates Abeta1-42-induced neuroinflammation and inhibits NF-kappaB pathway. PLoS ONE 9, e104745 (2014).","journal-title":"PLoS ONE"},{"key":"4947_CR12","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/jcmm.12124","volume":"17","author":"ZY Zhang","year":"2013","unstructured":"Zhang, Z. Y., Daniels, R. & Schluesener, H. J. Oridonin ameliorates neuropathological changes and behavioural deficits in a mouse model of cerebral amyloidosis. J. Cell. Mol. Med. 17, 1566\u20131576 (2013).","journal-title":"J. Cell. Mol. Med."},{"key":"4947_CR13","first-page":"452","volume":"32","author":"YJ Zhao","year":"2016","unstructured":"Zhao, Y. J. et al. Protective effects of oridonin on the sepsis in mice. J. Med. Sci. 32, 452\u2013457 (2016).","journal-title":"J. Med. Sci."},{"key":"4947_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1146\/annurev.immunol.021908.132715","volume":"27","author":"F Martinon","year":"2009","unstructured":"Martinon, F., Mayor, A. & Tschopp, J. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27, 229\u2013265 (2009).","journal-title":"Annu. Rev. Immunol."},{"key":"4947_CR15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1146\/annurev-immunol-031210-101405","volume":"29","author":"BK Davis","year":"2011","unstructured":"Davis, B. K., Wen, H. & Ting, J. P. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu. Rev. Immunol. 29, 707\u2013735 (2011).","journal-title":"Annu. Rev. Immunol."},{"key":"4947_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/cmi.2015.95","volume":"13","author":"EK Jo","year":"2016","unstructured":"Jo, E. K., Kim, J. K., Shin, D. M. & Sasakawa, C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell. Mol. Immunol. 13, 148\u2013159 (2016).","journal-title":"Cell. Mol. Immunol."},{"key":"4947_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/cmi.2016.13","volume":"15","author":"H Ahn","year":"2018","unstructured":"Ahn, H. et al. Poly-gamma-glutamic acid from Bacillus subtilis upregulates pro-inflammatory cytokines while inhibiting NLRP3, NLRC4 and AIM2 inflammasome activation. Cell. Mol. Immunol. 15, 111\u2013119 (2018).","journal-title":"Cell. Mol. Immunol."},{"key":"4947_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev.pathol.4.110807.092239","volume":"4","author":"G Chen","year":"2009","unstructured":"Chen, G., Shaw, M. H., Kim, Y. G. & Nunez, G. NOD-like receptors: role in innate immunity and inflammatory disease. Annu. Rev. Pathol. 4, 365\u2013398 (2009).","journal-title":"Annu. Rev. Pathol."},{"key":"4947_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/cmi.2016.29","volume":"14","author":"J Yang","year":"2017","unstructured":"Yang, J., Liu, Z. & Xiao, T. S. Post-translational regulation of inflammasomes. Cell. Mol. Immunol. 14, 65\u201379 (2017).","journal-title":"Cell. Mol. Immunol."},{"key":"4947_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev-cellbio-101011-155745","volume":"28","author":"M Lamkanfi","year":"2012","unstructured":"Lamkanfi, M. & Dixit, V. M. Inflammasomes and their roles in health and disease. Annu. Rev. Cell. Dev. Biol. 28, 137\u2013161 (2012).","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"key":"4947_CR21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ni.1831","volume":"11","author":"R Zhou","year":"2010","unstructured":"Zhou, R., Tardivel, A., Thorens, B., Choi, I. & Tschopp, J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11, 136\u2013140 (2010).","journal-title":"Nat. Immunol."},{"key":"4947_CR22","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/ni.2022","volume":"12","author":"H Wen","year":"2011","unstructured":"Wen, H. et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 12, 408\u2013415 (2011).","journal-title":"Nat. Immunol."},{"key":"4947_CR23","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/ni.1935","volume":"11","author":"SL Masters","year":"2010","unstructured":"Masters, S. L. et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat. Immunol. 11, 897\u2013904 (2010).","journal-title":"Nat. Immunol."},{"key":"4947_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237\u2013241 (2006).","journal-title":"Nature"},{"key":"4947_CR25","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell, P. et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357\u20131361 (2010).","journal-title":"Nature"},{"key":"4947_CR26","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2012","unstructured":"Heneka, M. T. et al. NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature 493, 674\u2013678 (2012).","journal-title":"Nature"},{"key":"4947_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/srep24399","volume":"6","author":"G Yang","year":"2016","unstructured":"Yang, G., Lee, H. E. & Lee, J. Y. A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet. Sci. Rep. 6, 24399 (2016).","journal-title":"Sci. Rep."},{"key":"4947_CR28","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1189\/jlb.3A0114-005RR","volume":"96","author":"H Honda","year":"2014","unstructured":"Honda, H. et al. Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation. J. Leukoc. Biol. 96, 1087\u20131100 (2014).","journal-title":"J. Leukoc. Biol."},{"key":"4947_CR29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll, R. C. et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat. Med. 21, 248\u2013255 (2015).","journal-title":"Nat. Med."},{"key":"4947_CR30","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.bbi.2016.12.014","volume":"61","author":"C Dempsey","year":"2017","unstructured":"Dempsey, C. et al. Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-beta and cognitive function in APP\/PS1 mice. Brain Behav. Immun. 61, 306\u2013316 (2017).","journal-title":"Brain Behav. Immun."},{"key":"4947_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","volume":"21","author":"YH Youm","year":"2015","unstructured":"Youm, Y. H. et al. The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat. Med. 21, 263\u2013269 (2015).","journal-title":"Nat. Med."},{"key":"4947_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12504","volume":"7","author":"MJ Daniels","year":"2016","unstructured":"Daniels, M. J. et al. Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer\u2019s disease in rodent models. Nat. Commun. 7, 12504 (2016).","journal-title":"Nat. Commun."},{"key":"4947_CR33","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1084\/jem.20171419","volume":"214","author":"H Jiang","year":"2017","unstructured":"Jiang, H. et al. Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders. J. Exp. Med. 214, 3219\u20133238 (2017).","journal-title":"J. Exp. Med."},{"key":"4947_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S2225-4110(16)30052-9","volume":"1","author":"MH Pan","year":"2011","unstructured":"Pan, M. H., Chiou, Y. S., Tsai, M. L. & Ho, C. T. Anti-inflammatory activity of traditional Chinese medicinal herbs. J. Tradit. Complement. Med. 1, 8\u201324 (2011).","journal-title":"J. Tradit. Complement. Med."},{"key":"4947_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature10558","volume":"479","author":"N Kayagaki","year":"2011","unstructured":"Kayagaki, N. et al. Non-canonical inflammasome activation targets caspase-11. Nature 479, 117\u2013121 (2011).","journal-title":"Nature"},{"key":"4947_CR36","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.cell.2014.02.008","volume":"156","author":"A Lu","year":"2014","unstructured":"Lu, A. et al. Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell 156, 1193\u20131206 (2014).","journal-title":"Cell"},{"key":"4947_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11929","volume":"7","author":"MS Dick","year":"2016","unstructured":"Dick, M. S., Sborgi, L., Ruhl, S., Hiller, S. & Broz, P. ASC filament formation serves as a signal amplification mechanism for inflammasomes. Nat. Commun. 7, 11929 (2016).","journal-title":"Nat. Commun."},{"key":"4947_CR38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","volume":"469","author":"R Zhou","year":"2011","unstructured":"Zhou, R., Yazdi, A. S., Menu, P. & Tschopp, J. A role for mitochondria in NLRP3 inflammasome activation. Nature 469, 221\u2013225 (2011).","journal-title":"Nature"},{"key":"4947_CR39","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.immuni.2013.05.016","volume":"38","author":"R Munoz-Planillo","year":"2013","unstructured":"Munoz-Planillo, R. et al. K(+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38, 1142\u20131153 (2013).","journal-title":"Immunity"},{"key":"4947_CR40","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1038\/sj.cdd.4402195","volume":"14","author":"V Petrilli","year":"2007","unstructured":"Petrilli, V. et al. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ. 14, 1583\u20131589 (2007).","journal-title":"Cell Death Differ."},{"key":"4947_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00227-x","volume":"8","author":"T Tang","year":"2017","unstructured":"Tang, T. et al. CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation. Nat. Commun. 8, 202 (2017).","journal-title":"Nat. Commun."},{"key":"4947_CR42","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/nature16959","volume":"530","author":"Y He","year":"2016","unstructured":"He, Y., Zeng, M. Y., Yang, D., Motro, B. & Nunez, G. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature 530, 354\u2013357 (2016).","journal-title":"Nature"},{"key":"4947_CR43","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/ni.3333","volume":"17","author":"H Shi","year":"2016","unstructured":"Shi, H. et al. NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component. Nat. Immunol. 17, 250\u2013258 (2016).","journal-title":"Nat. Immunol."},{"key":"4947_CR44","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1074\/jbc.C115.700492","volume":"291","author":"JL Schmid-Burgk","year":"2016","unstructured":"Schmid-Burgk, J. L. et al. A Genome-wide CRISPR (clustered regularly interspaced short palindromic repeats) screen identifies NEK7 as an essential component of NLRP3 inflammasome activation. J. Biol. Chem. 291, 103\u2013109 (2016).","journal-title":"J. Biol. Chem."},{"key":"4947_CR45","doi-asserted-by":"publisher","first-page":"8041","DOI":"10.1073\/pnas.0611496104","volume":"104","author":"JA Duncan","year":"2007","unstructured":"Duncan, J. A. et al. Cryopyrin\/NALP3 binds ATP\/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling. Proc. Natl Acad. Sci. USA 104, 8041\u20138046 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4947_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9771","volume":"6","author":"T Haq","year":"2015","unstructured":"Haq, T. et al. Mechanistic basis of Nek7 activation through Nek9 binding and induced dimerization. Nat. Commun. 6, 8771 (2015).","journal-title":"Nat. Commun."},{"key":"4947_CR47","doi-asserted-by":"publisher","first-page":"18118","DOI":"10.1074\/jbc.M110.209080","volume":"286","author":"L Regue","year":"2011","unstructured":"Regue, L. et al. DYNLL\/LC8 protein controls signal transduction through the Nek9\/Nek6 signaling module by regulating Nek6 binding to Nek9. J. Biol. Chem. 286, 18118\u201318129 (2011).","journal-title":"J. Biol. Chem."},{"key":"4947_CR48","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nrrheum.2011.207","volume":"8","author":"FM McQueen","year":"2012","unstructured":"McQueen, F. M., Chhana, A. & Dalbeth, N. Mechanisms of joint damage in gout: evidence from cellular and imaging studies. Nat. Rev. Rheumatol. 8, 173\u2013181 (2012).","journal-title":"Nat. Rev. Rheumatol."},{"key":"4947_CR49","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1002\/art.38747","volume":"66","author":"LL Reber","year":"2014","unstructured":"Reber, L. L. et al. Contribution of mast cell-derived interleukin-1beta to uric acid crystal-induced acute arthritis in mice. Arthritis Rheumatol. 66, 2881\u20132891 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"4947_CR50","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-pathol-012414-040431","volume":"10","author":"L Broderick","year":"2015","unstructured":"Broderick, L., De Nardo, D., Franklin, B. S., Hoffman, H. M., & Latz, E. The inflammasomes and autoinflammatory syndromes. Annu. Rev. Pathol. 10, 395\u2013424 (2015).","journal-title":"Annu. Rev. Pathol."},{"key":"4947_CR51","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.immuni.2013.05.015","volume":"38","author":"Y Yan","year":"2013","unstructured":"Yan, Y. et al. Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity 38, 1154\u20131163 (2013).","journal-title":"Immunity"},{"key":"4947_CR52","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.cmet.2010.11.011","volume":"12","author":"R Stienstra","year":"2010","unstructured":"Stienstra, R. et al. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab. 12, 593\u2013605 (2010).","journal-title":"Cell Metab."},{"key":"4947_CR53","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1074\/jbc.M113.515080","volume":"289","author":"Y He","year":"2014","unstructured":"He, Y. et al. 3,4-methylenedioxy-beta-nitrostyrene inhibits NLRP3 inflammasome activation by blocking assembly of the inflammasome. J. Biol. Chem. 289, 1142\u20131150 (2014).","journal-title":"J. Biol. Chem."},{"key":"4947_CR54","doi-asserted-by":"publisher","first-page":"9792","DOI":"10.1074\/jbc.M109.082305","volume":"285","author":"C Juliana","year":"2010","unstructured":"Juliana, C. et al. Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome. J. Biol. Chem. 285, 9792\u20139802 (2010).","journal-title":"J. Biol. Chem."},{"key":"4947_CR55","doi-asserted-by":"publisher","first-page":"10366","DOI":"10.1021\/jm501072b","volume":"57","author":"M Cocco","year":"2014","unstructured":"Cocco, M. et al. Electrophilic warhead-based design of compounds preventing NLRP3 inflammasome-dependent pyroptosis. J. Med. Chem. 57, 10366\u201310382 (2014).","journal-title":"J. Med. Chem."},{"key":"4947_CR56","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1002\/cmdc.201600055","volume":"11","author":"M Cocco","year":"2016","unstructured":"Cocco, M. et al. Design, synthesis, and evaluation of acrylamide derivatives as direct NLRP3 inflammasome inhibitors. Chem. Med. Chem 11, 1790\u20131803 (2016).","journal-title":"Chem. Med. Chem"},{"key":"4947_CR57","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.2174\/138955707782110105","volume":"7","author":"MM Santos","year":"2007","unstructured":"Santos, M. M. & Moreira, R. Michael acceptors as cysteine protease inhibitors. Mini Rev. Med. Chem. 7, 1040\u20131050 (2007).","journal-title":"Mini Rev. Med. Chem."},{"key":"4947_CR58","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrd3410","volume":"10","author":"J Singh","year":"2011","unstructured":"Singh, J., Petter, R. C., Baillie, T. A. & Whitty, A. The resurgence of covalent drugs. Nat. Rev. Drug. Discov. 10, 307\u2013317 (2011).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"4947_CR59","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.drudis.2015.05.005","volume":"20","author":"RA Bauer","year":"2015","unstructured":"Bauer, R. A. . Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies. Drug Discov. Today 20, 1061\u20131073 (2015).","journal-title":"Drug Discov. Today"},{"key":"4947_CR60","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1128\/MCB.26.3.735-742.2006","volume":"26","author":"A Didierlaurent","year":"2006","unstructured":"Didierlaurent, A. et al. Tollip regulates proinflammatory responses to interleukin-1 and lipopolysaccharide. Mol. Cell. Biol. 26, 735\u2013742 (2006).","journal-title":"Mol. Cell. Biol."},{"key":"4947_CR61","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201708689","volume":"10","author":"Y Huang","year":"2016","unstructured":"Huang, Y. et al. Tranilast directly targets NLRP3 to treat inflammasome-driven diseases. EMBO Mol. Med. 10, e8689 (2018).","journal-title":"EMBO Mol. Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-04947-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-04947-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-04947-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T10:11:29Z","timestamp":1671531089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-04947-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,29]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["4947"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-04947-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,29]]},"assertion":[{"value":"27 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2550"}}